title: Management of reflex sympathetic dystrophy.
abstract: Reflex sympathetic dystrophy (RSD) is currently defined as CRPS type I (complex regional pain syndrome). Due to the lack of comprehensive understanding of underlying pathophysiological mechanisms, a wide variety of therapeutic approaches are proposed, all of them being of unpredictable and variable efficacy. This is also due to the lack of controlled studies and randomized therapeutic trials. Most of the so-called "efficient" treatments are in fact based on anecdotal case reports and/or uncontrolled studies with small number of cases. Sympathetic blocks and active physiotherapy are, for many authors, the cornerstones of the efficient management. The role of prevention must be strongly emphasized, focusing, if RSD occurs following surgery, on the importance of pre- and postoperative efficient analgesia.
authors.affiliation: Department of Anesthesia, University Hospital, Nîmes, France.
authors.forename: E
authors.initials: E
authors.lastname: Viel
authors.forename: J
authors.initials: J
authors.lastname: Ripart
authors.forename: J
authors.initials: J
authors.lastname: Pelissier
authors.forename: J J
authors.initials: JJ
authors.lastname: Eledjam
mesh_terms: D000698:Analgesia; D001340:Autonomic Nerve Block; D006801:Humans; D008499:Medical Records; D026741:Physical Therapy Modalities; D011183:Postoperative Complications / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012019:Reflex Sympathetic Dystrophy / Q000145:classification / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D016896:Treatment Outcome